Evofem Biosciences, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 4.81 million compared to USD 2.35 million a year ago. Basic loss per share from continuing operations was USD 0.16 compared to USD 1.85 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0124 USD | -1.12% | -12.06% | -80.62% |
May. 16 | Transcript : Evofem Biosciences, Inc. - Special Call | |
May. 15 | Evofem Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-80.62% | 936K | |
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B |
- Stock Market
- Equities
- EVFM Stock
- News Evofem Biosciences, Inc.
- Evofem Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024